ÂÜÀòÂÒÂ×

Hylton Kalvaria is a seasoned professional in the life sciences industry, currently serving as the Chief Commercial Officer for Helix since August 2023 and an advisor at Rock Health Capital since March 2023. Kalvaria has extensive experience in advising healthcare companies on commercial strategies and market approaches, particularly in the realm of real-world data and evidence generation. Previous roles include President and Chief Commercial Officer at Mendel.ai, where work focused on developing advanced healthcare record-reading technology, and Chief Business Officer at Verana Health, contributing to oncology information management. Earlier positions include significant leadership roles at Flatiron Health and Genentech, where strategic initiatives aimed at improving cancer patient outcomes and analytics around biosimilars were key achievements. Kalvaria holds an MBA from Duke University's Fuqua School of Business and a BS in Economics from Duke University.